MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1
Cai Lv1, Zhiming Bai2, Zhenxiang Liu2
1Department of Urology, Haikou Municipal Hospital Haikou, Hainan, 570208, China ; Department of Urology, Renmin Hospital of Wuhan University Wuhan, Hubei, 430060, China.
Abstract:
Deregulated expression of miRNAs is related to progression and initiation of human cancers. Although miR-495 has identified in various tumors, its expression and function in renal cell carcinoma (RCC) is still unknown. In this study, we found that the expression of miR-495 was downregulated in RCC cell lines and tissues. Ectopic expression of miR-495 induced G0/G1 phase arrest and suppressed cell proliferation and migration in RCC cell lines. We further validated SATB1 was a direct target of miR-495 in RCC. In addition, re-expression of SATB1 reversed the miR-495-induced inhibition of cell proliferation and migration. These data suggest that miR-495 functions as a tumor suppressor and may be a promising therapeutic target in RCC in the future.
Insights
MicroRNA-495 (miR-495) is downregulated in renal cell carcinoma (RCC). Restoring miR-495 suppresses RCC cell growth and migration by targeting SATB1, suggesting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
- The role of miR-495 in renal cell carcinoma (RCC) remains largely unexplored.
Purpose of the Study:
- To investigate the expression and function of miR-495 in RCC.
- To identify potential targets of miR-495 in RCC.
Main Methods:
- Quantitative real-time PCR to assess miR-495 expression in RCC cell lines and tissues.
- Cell proliferation, migration assays, and cell cycle analysis to evaluate miR-495 function.
- Luciferase reporter assays and Western blotting to validate SATB1 as a direct target of miR-495.
Main Results:
- miR-495 expression was significantly downregulated in RCC cell lines and tissues compared to normal controls.
- Ectopic expression of miR-495 induced G0/G1 phase arrest, suppressed cell proliferation, and inhibited cell migration in RCC cells.
- SATB1 was identified as a direct target of miR-495 in RCC.
- Re-expression of SATB1 partially reversed the inhibitory effects of miR-495 on cell proliferation and migration.
Conclusions:
- miR-495 acts as a tumor suppressor in renal cell carcinoma.
- miR-495 may serve as a potential diagnostic biomarker and therapeutic target for RCC.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...


